Wednesday, July 8, 2026

pharma · Coronary Artery Bypass Grafting · Hypertension Pulmonary Secondary · TENX

TENAX THERAPEUTICS

TENAX THERAPEUTICS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Chapel Hill, USA HQ
19 Employees
Public company Type
TENX · NYSE Ticker
Company details
Status
Public
HQ
Chapel Hill, USA
Employees
19
Programs
7
Drugs
2
Patents
4
Intelligence · Drug Pipeline

TENAX THERAPEUTICS pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

TENAX THERAPEUTICS drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to TENAX THERAPEUTICS in public FDA and regional records.

  2. Development asset linked to TENAX THERAPEUTICS in public FDA and regional records.